These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9142198

  • 1. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
    Kerbl R, Urban CE, Ladenstein R, Ambros IM, Spuller E, Mutz I, Amann G, Kovar H, Gadner H, Ambros PF.
    Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
    [Abstract] [Full Text] [Related]

  • 2. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
    Kerbl R, Urban CE, Ladenstein R, Schnellauf C, Sitzwohl C, Lackner H, Gleispach H, Fauler G, Ambros PF, Ambros IM, Rumpler S, Gadner H, Spuller E, Höfler G, Amann G, Kytir J, Mutz I.
    Wien Klin Wochenschr; 1996 Jul; 108(13):398-403. PubMed ID: 8766424
    [Abstract] [Full Text] [Related]

  • 3. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T, Kohno S, Mimaya J, Hasegawa S, Urushihara N, Yoshida A, Kawano S, Kusafuka J, Horikoshi Y, Takashima Y, Aoki K, Hamazaki M.
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [Abstract] [Full Text] [Related]

  • 4. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E, Iehara T, Sugimoto T, Fukuzawa M, Hayashi Y, Sasaki F, Sugiyama M, Kondo S, Yoneda A, Yamaoka H, Tajiri T, Akazawa K, Ohtaki M.
    Lancet; 2008 Apr 05; 371(9619):1173-80. PubMed ID: 18395578
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
    Kerbl R, Urban CE, Ambros IM, Dornbusch HJ, Schwinger W, Lackner H, Ladenstein R, Strenger V, Gadner H, Ambros PF.
    J Clin Oncol; 2003 Nov 15; 21(22):4228-34. PubMed ID: 14615452
    [Abstract] [Full Text] [Related]

  • 7. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA, Hachitanda Y, Woods WG, Tuchman M, Lemieux B, Brisson L, Bernstein M, Brossard J, Leclerc JM, Byrne TD.
    Cancer; 1995 Dec 01; 76(11):2363-71. PubMed ID: 8635044
    [Abstract] [Full Text] [Related]

  • 8. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman DH, Sander J.
    J Clin Oncol; 1999 Apr 01; 17(4):1200. PubMed ID: 10561179
    [Abstract] [Full Text] [Related]

  • 9. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 01; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 10. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T, Ohta S, Tani T, Mizukuro T, Mekata E, Naitoh H, Shimadera S, Fujino S, Taga T.
    Pediatr Surg Int; 2002 Sep 01; 18(5-6):289-94. PubMed ID: 12415341
    [Abstract] [Full Text] [Related]

  • 11. One hundred neuroblastomas detected through a mass screening system in Japan.
    Hachitanda Y, Ishimoto K, Hata J, Shimada H.
    Cancer; 1994 Dec 15; 74(12):3223-6. PubMed ID: 7982186
    [Abstract] [Full Text] [Related]

  • 12. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A.
    Gan To Kagaku Ryoho; 1990 Dec 15; 17(12):2319-26. PubMed ID: 2260868
    [Abstract] [Full Text] [Related]

  • 13. Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria.
    Kerbl R, Urban CE, Ambros PF, Lackner H, Ladenstein R, Spuller E, Mutz I, Ambros I, Amann G, Gadner H, Parker L.
    Eur J Cancer; 1996 Dec 15; 32A(13):2298-305. PubMed ID: 9038613
    [Abstract] [Full Text] [Related]

  • 14. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S, Zaizen Y, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Ueda K, Tasaka H, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Yano H, Akiyama H, Ikeda K.
    J Pediatr Surg; 1996 Apr 15; 31(4):555-8. PubMed ID: 8801312
    [Abstract] [Full Text] [Related]

  • 15. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B.
    Lancet; 1996 Apr 15; 348(9043):1682-7. PubMed ID: 8973429
    [Abstract] [Full Text] [Related]

  • 16. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S, Hirakawa H, Ueno S, Yabe H, Hiraoka N.
    Pediatrics; 1999 May 15; 103(5):e67. PubMed ID: 10224211
    [Abstract] [Full Text] [Related]

  • 17. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T.
    Med Pediatr Oncol; 1997 Feb 15; 28(2):81-91. PubMed ID: 8986143
    [Abstract] [Full Text] [Related]

  • 18. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
    Ater JL, Gardner KL, Foxhall LE, Therrell BL, Bleyer WA.
    Cancer; 1998 Apr 15; 82(8):1593-602. PubMed ID: 9554539
    [Abstract] [Full Text] [Related]

  • 19. Mass-screening of neuroblastoma using urine from infants by high-performance liquid chromatographic method: results of first (6th month) and second (14th month) screening.
    Takeda T, Shimada M, Nishi M, Hanai J, Kikuchi Y.
    J Neurooncol; 1997 Jan 15; 31(1-2):165-70. PubMed ID: 9049845
    [Abstract] [Full Text] [Related]

  • 20. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
    Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T.
    Early Hum Dev; 1996 Sep 20; 46(1-2):177-96. PubMed ID: 9019414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.